Thomas D. Morel
Thomas D. Morel publishes mostly in Neurology, Economics and Econometrics and Genetics, on topics such as Parkinson's Disease Mechanisms and Treatments, Health Systems, Economic Evaluations, Quality of Life and Genomics and Rare Diseases.
- World rank
- #791,876 of 7,710,434 ranked researchers
- Rank in Belgium
- #7,240 of 67,186
- Works
- 60
- Citations
- 1.5k
- Citations per work
- 25.0
What does Thomas D. Morel research?
Thomas D. Morel's work is mostly in Medicine (31%), Economics, Econometrics and Finance (13%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2643.0%
- Health Sciences2235.9%
- Medicine1931.4%
- Health Professions34.5%
- Social Sciences812.8%
- Life Sciences58.3%
- 1Neurology20% of their works
- 2Economics and Econometrics13% of their works
- 3Genetics8% of their works
- 4Rheumatology6% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6General Health Professions4% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Genomics and Rare Diseases
- Parkinson's Disease and Spinal Disorders
- Systemic Lupus Erythematosus Research
- Pharmaceutical Economics and Policy
- Neurological disorders and treatments
- Myasthenia Gravis and Thymoma
Which keywords describe Thomas D. Morel's research?
The keywords of their largest research topics: Parkinson's Disease, Deep Brain Stimulation, Neurological Disorders, a-Synuclein, Cost-effectiveness Analysis, Neurodegeneration, Quality of Life and Autoantibodies.
- Thymic Tumors
- Subthalamic Nucleus
- Systemic Lupus Erythematosus
- Drug Development Costs
- Dropped Head Syndrome
- Sequence Interpretation
- Autoantibodies
- Quality of Life
- Cost-effectiveness Analysis
- Deep Brain Stimulation
- Parkinson's Disease
- Neurological Disorders
- Neurodegeneration
- a-Synuclein
- Genetic Variants
- Camptocormia
- Antiphospholipid Syndrome
- Generic Drugs
- Basal Ganglia
- Myasthenia Gravis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Parkinson's Disease263 topics
- Deep Brain Stimulation142 topics
- Neurological Disorders142 topics
- Cost-effectiveness Analysis121 topic
- Neurodegeneration121 topic
- Quality of Life121 topic
- a-Synuclein121 topic
- Autoantibodies112 topics
- Genetic Variants91 topic
- Sequence Interpretation91 topic
- Camptocormia81 topic
- Dropped Head Syndrome81 topic
- Antiphospholipid Syndrome71 topic
- Drug Development Costs71 topic
- Generic Drugs71 topic
- Systemic Lupus Erythematosus71 topic
- Basal Ganglia61 topic
- Subthalamic Nucleus61 topic
- Myasthenia Gravis41 topic
- Thymic Tumors41 topic
Where does Thomas D. Morel work?
Thomas D. Morel's main affiliation in the publication record is UCB Pharma (Belgium), Belgium.
How many publications and citations does Thomas D. Morel have?
OpenAlex counts 60 works and 1,497 citations for Thomas D. Morel, an h-index of 17, ranking #791,876 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas D. Morel. Posts are plain text and can be reported.